Details

NameSymbolSector
TORRENT PHARMACEUTICALS LIMITEDTORNTPHARMPharmaceuticals
Open
3552
High
3566.9
Low
3504
Close
3514.7
Volume
382209
Exchange
nse
Time
03-Oct-2025

Outlook

Score:

0.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofTorrentPharmaceuticalsis
None
EstimatedStoplossofTorrentPharmaceuticalsis
3566.9
TorrentPharmaceuticalshasa
Bearishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofTorrentPharmaceuticalsis
Unpredictableℹ
.

Trend

TorrentPharmaceuticalsisin
Sideways trendℹ
.
PriceofTorrentPharmaceuticalsis
Downℹ
by

2.24

%.
Target
Buy@

3405.23

Sell@

3752.35

Current@

3514.7

Volume

TorrentPharmaceuticalshasseen
Moderateℹ
volumeoftrades.
ThevolumetrendforTorrentPharmaceuticalsis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofTorrentPharmaceuticalsis

Up

by

10.66

%

Valuation

ThecurrentmarketpriceofTorrentPharmaceuticalsis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth14989crandtotalassetsworth14989cr,thebalancesheetofTorrentPharmaceuticalsis:
Balancedℹ
.
Cashflow
TorrentPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 261cr

.Itis
Downℹ
by

180.06

%.
47.61% i.e. ₹ 2585cr earned in operatingℹ
9.94% i.e. ₹ 540cr spent in investingℹ
42.3% i.e. ₹ 2297cr spent in financingℹ
0.15% i.e. ₹ 8cr spent in otherℹ
TorrentPharmaceuticalshas
Excellentℹ
cashflowbecausethereis

Surplus

of

₹ 326cr

.Itis
Upℹ
by

196.36

%.
52.51% i.e. ₹ 3266cr earned in operatingℹ
2.68% i.e. ₹ 167cr spent in investingℹ
44.68% i.e. ₹ 2779cr spent in financingℹ
0.13% i.e. ₹ 8cr earned in otherℹ
Income
TheincomeofTorrentPharmaceuticalsis

₹ 3141cr

and

Profit

is:

₹ 548cr

TorrentPharmaceuticalsProfitisupby:

10.04

%andIncomeisUpby:

6.8

%
TheincomeofTorrentPharmaceuticalsis

₹ 2941cr

and

Profit

is:

₹ 498cr

TorrentPharmaceuticalsProfitisdownby:

0.99

%andIncomeisUpby:

3.48

%
TheincomeofTorrentPharmaceuticalsis

₹ 2842cr

and

Profit

is:

₹ 503cr

TorrentPharmaceuticalsProfitisupby:

11.04

%andIncomeisDownby:

1.08

%
By using this site you agree to the use of cookies to deliver a better site experience.